Logos Global Management LP Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$853.6T
Holdings
40
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IDYAIDEAYA BIOSCIENCES INC | 3,900,000 | $70.9T | 8.30% | |
| 2 | APLSAPELLIS PHARMACEUTICALS INC | 1,350,000 | $69.8T | 8.18% | |
| 3 | CYTKCYTOKINETICS INC | 1,500,000 | $68.7T | 8.05% | |
| 4 | IMVTIMMUNOVANT INC | 3,150,000 | $55.9T | 6.55% | |
| 5 | ALLKGUSDALLAKOS INC | 5,286,666 | $44.5T | 5.21% | |
| 6 | BCYCBICYCLE THERAPEUTICS PLC | 1,435,000 | $42.5T | 4.98% | |
| 7 | XENEXENON PHARMACEUTICALS INC | 900,000 | $35.5T | 4.16% | |
| 8 | OPHTEURIVERIC BIO INC | 1,500,000 | $32.1T | 3.76% | |
| 9 | KRTXKARUNA THERAPEUTICS INC | 150,000 | $29.5T | 3.45% | |
| 10 | VRDNVIRIDIAN THERAPEUTICS INC | 1,000,000 | $29.2T | 3.42% | |
| 11 | DSGNDESIGN THERAPEUTICS INC | 2,797,501 | $28.7T | 3.36% | |
| 12 | IMCRIMMUNOCORE HLDGS PLC | 500,000 | $28.5T | 3.34% | |
| 13 | SRPTSAREPTA THERAPEUTICS INC | 220,000 | $28.5T | 3.34% | |
| 14 | ALXOALX ONCOLOGY HLDGS INC | 2,349,600 | $26.5T | 3.10% | |
| 15 | DYNDYNE THERAPEUTICS INC | 2,150,000 | $24.9T | 2.92% | |
| 16 | AKROAKERO THERAPEUTICS INC | 400,000 | $21.9T | 2.57% | |
| 17 | VTYXVENTYX BIOSCIENCES INC | 657,016 | $21.5T | 2.52% | |
| 18 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,400,000 | $20.7T | 2.43% | |
| 19 | —DICE THERAPEUTICS INC | 660,000 | $20.6T | 2.41% | |
| 20 | MDGLMADRIGAL PHARMACEUTICALS INC | 60,000 | $17.4T | 2.04% | |
| 21 | RCKTROCKET PHARMACEUTICALS INC | 750,000 | $14.7T | 1.72% | |
| 22 | FULCFULCRUM THERAPEUTICS INC | 2,000,000 | $14.6T | 1.71% | |
| 23 | CATBUSDASTRIA THERAPEUTICS INC | 864,960 | $12.9T | 1.51% | |
| 24 | COGTCOGENT BIOSCIENCES INC | 1,100,000 | $12.7T | 1.49% | |
| 25 | GONGERON CORP | 4,000,000 | $9.7T | 1.13% | |
| 26 | OLMAOLEMA PHARMACEUTICALS INC | 3,743,875 | $9.2T | 1.07% | |
| 27 | FGENEURFIBROGEN INC | 525,000 | $8.4T | 0.99% | |
| 28 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 260,000 | $8.2T | 0.96% | |
| 29 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,250,000 | $7.8T | 0.92% | |
| 30 | ANABANAPTYSBIO INC | 250,000 | $7.7T | 0.91% | |
| 31 | RETAEURREATA PHARMACEUTICALS INC | 180,000 | $6.8T | 0.80% | |
| 32 | VERAVERA THERAPEUTICS INC | 285,000 | $5.5T | 0.65% | |
| 33 | —PROMETHEUS BIOSCIENCES INC | 50,000 | $5.5T | 0.64% | |
| 34 | RAPTEURRAPT THERAPEUTICS INC | 200,000 | $4.0T | 0.46% | |
| 35 | MOR2MORPHOSYS AG | 900,000 | $3.2T | 0.38% | |
| 36 | VIGLVIGIL NEUROSCIENCE INC | 188,390 | $2.4T | 0.28% | |
| 37 | SPRBSPRUCE BIOSCIENCES INC | 1,000,000 | $1.1T | 0.13% | |
| 38 | TYRATYRA BIOSCIENCES INC | 110,856 | $842.5B | 0.10% | |
| 39 | LIANYLIANBIO | 280,000 | $459.2B | 0.05% | |
| 40 | NUVB/WSNUVATION BIO INC | 66,666 | $9.6B | 0.00% |